BioCentury | Jan 6, 2014
Finance

4Q Stock Wrap-Up: All's well that ends well

...17% to ~55 $5.3 0.58 9/30/13 $2.3 (A) Focusing on speeding up adoption of its AXP AutoXpress Platform...
BioCentury | Nov 11, 2013
Company News

Thermogenesis hematology news

...million per year. The company said it will focus on speeding up adoption of its AXP AutoXpress Platform...
BioCentury | Oct 15, 2007
Clinical News

AXP AutoXpress Platform regulatory update

...FDA granted 510(k) clearance for KOOL's AXP AutoXpress Platform to isolate and capture stem cells from umbilical cord...
...device and companion sterile closed blood processing disposable. ThermoGenesis Corp. (KOOL), Rancho Cordova, Calif. Product: AXP AutoXpress Platform...
Items per page:
1 - 3 of 3